Immune Treatment Strategies in Unexplained Recurrent Pregnancy Loss

Documenti analoghi

• Comment on—Intravenous Immunoglobulin Use in Patients With Unexplained Recurrent Pregnancy Loss
  di: Yasemin Akgul Balaban
  Pubblicazione: (2025)
• Clinical Features Between Primary Obstetric Antiphospholipid Syndrome and Non‐Criteria Obstetric Antiphospholipid Syndrome and Risk Factors of Adverse Pregnancy Outcomes: A Retrospective Study of 1006 Cases
  di: Huimin Liu, et al.
  Pubblicazione: (2024)
• The Impact of Microbiota‐Mediated Immune Regulation on Recurrent Pregnancy Loss and Intervention Strategies
  di: Yao Yao, et al.
  Pubblicazione: (2025)
• Mechanisms and Therapeutic Implications of Microbiome‐Mediated Immune Dysregulation in Recurrent Pregnancy Loss and Implantation Failure
  di: Wael Bahia, et al.
  Pubblicazione: (2026)
• Autoimmune Condition Diagnosis Following Recurrent Pregnancy Loss
  di: Marisa R. Imbroane, et al.
  Pubblicazione: (2024)